Clinical Trials and Research
Making Progress Every Single Day
Last year, more than 3,300 people participated in clinical trials at the Cancer Center, leading to new knowledge and breakthrough therapies. Our clinical trials offer access to tomorrow's therapies today.
Progress in Targeted Cancer Care
Eradicating cancer takes commitment and creativity. We have both. Commitment to explore novel combinations of therapies. Creativity to collaborate, apply learnings, and advance treatment options.
Henri and Belinda Termeer Center for Targeted Therapies
The Termeer Center offers a comprehensive translational research program to speed the discovery and delivery of new targeted therapies to patients with early and advanced stage cancers.
Leapfrog Moments in Cancer Therapies with Keith Flaherty, MD
With so many new cancer treatments in development and now available, cancer care is fundamentally different than it was just a few years ago. Go behind the scenes with our Director of Clinical Research, Dr. Keith Flaherty, to learn how teams of researchers and clinicians are applying scientific insights to propel the creation of new therapies for patients.
Progress in Immunotherapy
The Mass General Cancer is proud to be an authorized treatment center for two FDA approved CAR T-cell therapies for adult patients with lymphoma. Where, before, patients were given little or no hope, now there is real and meaningful scientific progress. Today it's lymphoma and CAR-T therapy. Tomorrow? We think big so you can dream big.
Progress in Early Cancer Detection
Center for Innovation in Early Cancer Detection
The Center for Innovation in Early Cancer Detection seeks to pair cancer detection technologies with clinical resources – with the goal of improving early cancer detection and treatment.
Browse Cancer Center Research Labs
Browse Research Areas